when rimonabant will be approved

People are asking when rimonabant will be approved.

Not for a few years...and possibly never.

Rimonabant (Acomplia, Zimulti) has been in the news as a promising drug for obesity, smoking cessation, dyslipidemia, and diabetes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote